Colgate-Palmolive Company
NYSE:CLHousehold & Personal Products
-$0.71 today
- Market cap
- $78.58B
- Beta
- 0.32
- P/E (TTM)
- 34.5
- EPS (TTM)
- $2.60
- Dividend yield
- 2.33%
Volume 6.07M
Average 5.62M
CL Change in Working Capital
Cash absorbed or released by changes in receivables, inventory, payables, and other operating balances.
Colgate-Palmolive CompanyNYSE: CL
Change in Working Capital · Q3 FY2026 · quarter ended Sep 2026
Change in working capital dips below year-ago levels
Q3 FY2026 change in working capital of $155M fell 35.7% year over year, behind the +151.5% change in trailing-twelve-month change in working capital. Sequentially, it rose 1191.7% from the prior quarter.
Context
- Change in working capital amounted to 1.4% of revenue in FY2025, down 0.3 pp from a year earlier.
- Change in working capital increased in 1 of the last 3 fiscal years.
What to watch
Whether quarterly growth recovers from -35.7% toward the trailing-twelve-month pace of +151.5%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Change in Working Capital history
USD · from the cash flow
- Latest · FY2025
- 284M USD
- Year-over-year change
- -17.4%
| Period | Period end | Change in Working Capital | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 284M | -17.4% |
| FY2024 | 2024-12-31 | 344M | -24.4% |
| FY2023 | 2023-12-31 | 455M | +162.7% |
| FY2022 | 2022-12-31 | (726M) | -268.5% |
| FY2021 | 2021-12-31 | (197M) | — |
Change in Working Capital vs competitors
How CL compares with its peers on the latest reported figures
- Peers report in different currencies, so change in working capital is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of +151.5% is the 4th highest of 7, against a peer median of +141.3%.
- Change in working capital amounts to 1.6% of revenue for CL, versus a peer median of 2.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $1.07B USD | +773.0% | +204.5% | 6.5% | |
| LTM Sep 2026 | $533M USD | -82.5% | — | 0.6% | |
| LTM Sep 2026 | $514M USD | +96.2% | — | 3.3% | |
| LTM Sep 2026 | $337M USD | +151.5% | — | 1.6% | |
| LTM Sep 2026 | $245M USD | +186.6% | -30.7% | 3.4% | |
| FY2025 | €111.42M EUR | +127.6% | — | 0.2% | |
| LTM Sep 2026 | $21.9M USD | +155.0% | — | 0.4% | |
| Peer median (excluding CL) | — | +141.3% | +86.9% | 2.0% | |
Competitors are the stored peer set for CL. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 2.34B | 1.97B | 2.46B | 3.05B | 2.13B |
| Depreciation & Amortization | 556M | 545M | 567M | 605M | 630M |
| Deferred Income Tax | (132M) | (78M) | (98M) | (77M) | (109M) |
| Stock-Based Compensation | 135M | 125M | 122M | 135M | 0 |
| Change in Working Capital | (197M) | (726M) | 455M | 344M | 284M |
| Accounts Receivables | (84M) | (227M) | (37M) | (56M) | (16M) |
| Inventory | (72M) | (333M) | 194M | (100M) | 109M |
| Accounts Payables | 0 | 0 | 0 | 516M | 251M |
| Other Working Capital | (41M) | (166M) | 298M | (16M) | (60M) |
| Other Non-Cash Items | 625M | 723M | 244M | 51M | 1.26B |
| Operating Cash Flow | 3.33B | 2.56B | 3.75B | 4.11B | 4.2B |
| Capital Expenditures | (567M) | (696M) | (705M) | (561M) | (564M) |
| Acquisitions (Net) | 0 | (809M) | 0 | 0 | (293M) |
| Purchases of Investments | (141M) | (470M) | (506M) | (574M) | (698M) |
| Sales of Investments | 141M | 322M | 502M | 564M | 752M |
| Other Investing Activities | (25M) | 52M | (33M) | 37M | (14M) |
| Investing Cash Flow | (592M) | (1.6B) | (742M) | (534M) | (817M) |
| Debt Repayment | (175M) | 1.65B | (314M) | (408M) | (456M) |
| Common Stock Issued | 0 | 0 | 0 | 0 | 101M |
| Common Stock Repurchased | (1.32B) | (1.31B) | (1.13B) | (1.74B) | (1.21B) |
| Dividends Paid | (1.68B) | (1.69B) | (1.75B) | (1.79B) | (1.82B) |
| Other Financing Activities | 400M | 400M | 398M | 547M | 132M |
| Financing Cash Flow | (2.77B) | (952M) | (2.79B) | (3.39B) | (3.26B) |
| Effect of Forex Changes | (15M) | (60M) | (19M) | (54M) | 67M |
| Net Change in Cash | (56M) | (57M) | 191M | 130M | 192M |
| Free Cash Flow | 2.76B | 1.86B | 3.04B | 3.55B | 3.63B |
Colgate-Palmolive Company
NYSE:CL
Intrinsic Alpha fair value
Locked
Current Price
$98.85
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.